YBX1 mediates translation of oncogenic transcripts to control cell competition in AML
收藏NIAID Data Ecosystem2026-03-12 收录
官方服务：
资源简介：
This SuperSeries is composed of the SubSeries listed below. Refer to individual Series
应用场景：
创建时间：
2021-09-07
相关数据集
A Novel Human TPIP Splice-Variant (TPIP-C2) mRNA, Expressed in Human and Mouse Tissues, Strongly Inhibits Cell Growth in HeLa Cells
Alternative splicing of mRNAs is known to involve a major regulation of gene expression at RNA level in mammalian cells. The PTEN (Phosphatase and TENsin homologue deleted from the human chromosome 10
NIAID Data Ecosystem60
JNK Controls the Onset of Mitosis in Planarian Stem Cells and Triggers Apoptotic Cell Death Required for Regeneration and Remodeling
Regeneration of lost tissues depends on the precise interpretation of molecular signals that control and coordinate the onset of proliferation, cellular differentiation and cell death. However, the na
Figshare2016-01-15 更新30
RNA-Seq analysis to compare immature myeloid cells from PARP1CKO and PARP2CKO mice with their corresponding littermate controls. RNA-Seq analysis to compare immature myeloid cells from PARP1CKO and PARP2CKO mice with their corresponding littermate controls
We compared expression profiles of immature myeloid cells from PARP1CKO and PARP2CKO mice with their corresponding littermate controls by Next-generation sequencing (NGS). The results showed that gene
NIAID Data Ecosystem20
Signaling network diversification during differentiation sensitizes AML cells to PAK and MEK inhibitors
A main requirement for precision medicine is the identification of patients that are more likely to respond to a particular drug. AML is a heterogeneous disease in which molecules associated to kinase
NIAID Data Ecosystem30
Deep sequencing of an AML cell line, with and without p53, treated with vehicle control, BETi, MDM2i, or a drug combination. Deep sequencing of an AML cell line, with and without p53, treated with vehicle control, BETi, MDM2i, or a drug combination
Gene expression changes were compared in human OCI-AML3 cells, with or without p53 knock down, that were treated with DMSO (vehicle control), the BET inhibitor CPI-203, the MDM2 inhibitor Nutlin-3a, o
NIAID Data Ecosystem20
